Biohaven

Clinical trials are designed to push the boundaries of medical #innovation. We're enrolling patients now to advance cutting-edge #research across multiple diseases. For more information on our ongoing #clinicaltrials, visit: https://bit.ly/4bJ7HCP #ClinicalTrialsDay #CTD2024

With 7,000 rare diseases affecting 1 in 10 Americans—and 95% lacking an FDA-approved treatment—there is still much work to do. At Biohaven, we’re dedicated to advancing scientific research and developing much-needed therapies for rare disease patients. Read Melissa Wolfe Beiner, our Senior Medical Director’s perspective on why collaboration and innovation are key to making a difference: https://brnw.ch/21wR1nu #RareDiseaseDay #DaysMatter

In recognition of #RareDiseaseDay, we’re proud to share our dedication to advancing research for rare diseases like #spinocerebellarataxia and #spinalmuscularatrophy. #DaysMatter for those living with #SCA and #SMA, and we are committed to improving their lives through advancing research. #ShowYourStripes #SCAawareness #ataxia #SMAawareness

In the first episode of our new video series, our principal investigator Charlotte Bredo Spliid, Ph.D. explains how we’re breaking boundaries in precision #immunology to help transform the treatment of severe diseases. Check out “Insights on Innovation” to learn how we’re working to solve the toughest medical challenges and meet the scientists making it happen. #Sciencein60 #DaysMatter

Our new video series, “Insights on Innovation” explores the cutting-edge scientific approaches we’re pursuing across our diverse portfolio in #neuroscience, #immunology, and #oncology. Told through the voices of our scientists and researchers, the series brings you closer to our efforts to turn breakthrough science into transformative new medicines. #Sciencein60

In a recent conversation with Clinical Leader, Jason Lerner, M.D., our medical director and clinical lead for #epilepsy, shared how his approach to #clinicaltrials prioritizes reducing barriers for trial participants while delivering innovative solutions to meet both patient and regulatory needs. By integrating virtual visits, at-home care, and simplified digital tools, we aim to make participation more accessible and impactful: https://bit.ly/40FHhzf

With leaders like Laura Heller, our Vice President and Head of Medical Affairs, we’re building a team driven by passion, purpose, and a commitment to finding solutions that make a difference for patients. Learn what it means to #BeBiohaven: https://bit.ly/4g6zbVO #CompanyCulture

Vlad Coric, M.D. will be a featured guest amongst a lineup of inspiring New Haven leaders for an evening dedicated to community impact and innovation with Leadership, Education and Athletics in Partnership, Inc.! Join him on February 27 at ZINC Restaurant in support of educational opportunities for local youth as he shares his career journey and the story behind Biohaven’s growth: https://bit.ly/3QbrHFq #LEAPYearEvent #NewHaven

Our #epilepsy clinical trial is exploring a potential therapy to improve #seizure management. In a recent Living Well With Epilepsy article, Anne Neumann RN BSN, our Global Patient Advocacy and Marketing Lead, shared how her personal and professional journey drives her commitment to supporting patients and caregivers: https://bit.ly/4at1iMU

#NEWS: The FDA has accepted for review our #NewDrugApplication for our investigational therapy for adult patients with #spinocerebellarataxia and has granted Priority Review. If approved, this would be the first and only FDA-approved treatment for #SCA, a rare, inherited and devastating #neurdegenerative disorder. Learn more about our plans: https://bit.ly/3EBSqZC